Advertising

Clinical
Volume 53, Issue 11 Suppl, November Supplement 2024

Penile dermatology for the general practitioner: A pragmatic approach to diagnosis and management

Henry YC Pan    David Homewood    Jonathan S O’Brien    Justin Chee    Nathan Lawrentschuk    Anthony P Hall   
doi: 10.31128/AJGP-01-24-7111   |    Download article
Cite this article    BIBTEX    REFER    RIS

Background

Genital skin conditions are rare and pose a diagnostic challenge due to their diverse pathology. Patient anxiety and referral decisions add complexity for primary caregivers. Demographics and overlapping symptoms complicate diagnosis, causing anxiety for both patients and clinicians. Social stigma and apprehension to seek healthcare might delay treatment. Accurate differentiation between benign and potentially serious conditions is crucial.

Objective

We aim to provide clinicians with a clear and concise framework to assist them in risk stratification, treatment decisions and referral pathways for common genital skin conditions.

Discussion

Differentiating normal variations is crucial to minimise unnecessary investigations and alleviate patient anxiety. Circumcision status, pigmentation and genetics influence disease presentation. We highlight benign conditions for reassurance. Inflammatory genital lesions might arise from various causes. Biopsies remain essential for accurately diagnosing uncertain cases. Sexually transmitted infections (STIs) should be promptly diagnosed and treated. Neoplastic conditions can evolve rapidly, requiring an urgent specialist referral.

 

Male genital dermatoses are nuanced and demanding presentations for general practitioners (GPs). Their diverse clinical presentations and cross-specialty referral pathways can be onerous to navigate. Recognising and initiating management in the primary care setting is critical, and determining when to seek subspecialist advice remains controversial. The interplay of diverse demographics, patient anxiety and overlapping signs and symptoms often complicate the diagnostic pathway. Social stigma and reluctance to seek medical attention is a common reason for delayed treatment. Accurately distinguishing between normal variations, benign presentations and potentially infectious or malignant conditions is paramount to reducing morbidity and improving public health.

Aim

We aim to provide an up-to-date and concise framework to guide clinicians in their risk stratification and decisions for treatment, and potential referral of these conditions.

History and examination

Establishing a safe and culturally sensitive rapport is paramount when assessing penile dermatological concerns.1 A thorough examination, using accurate descriptors of the dermatosis, is essential for documentation and potential referrals. Take note of circumcision status and location of the abnormality, and compare findings with the skin condition elsewhere on the body.2 Clinical photography with patient consent is a valuable diagnostic aid and is being increasingly used in artificial intelligence–augmented diagnostic tools.3

Non-malignant/non-infectious conditions
Normal penile dermatological variation

Normal genital skin variations are common and can produce anxiety for patients and physicians. It is crucial to distinguish normal variants from treatable pathology to minimise unnecessary investigations and alleviate patient concerns.

In circumcised males, the glans epithelium becomes keratinised, and might appear purple. Similarly, there are variations in scrotal colour and the hue of the midline raphe.4

Variations can be attributed to skin phototypes, ancestry/ethnicity and genetic factors. Although reassurance is adequate, pigmentation changes might also accompany inflammatory diseases, and normal pigmentation differences can impact a patient’s sexuality and psychological wellbeing.

Common benign presentations

Pearly penile papules are common, presenting as tiny pale papules localised to the coronal sulcus, and might form multiple rows (Figure 1A). Fordyce spots are ectopic sebaceous glands appearing as pale micropapules (Figure 1B).

Median raphe cysts are benign, pale, fluid-filled sacs along the scrotal raphae (Figure 1C). Angiokeratoma of Fordyce are vascular malformations appearing as tiny red–purple scrotal spots that might occasionally bleed (Figure 1D). These conditions do not require intervention, and offering reassurance and observation is safe.


Figure 1. Photographic examples of common benign penile dermatological presentations. (A) Benign pearly penile papules; (B) Fordyce spots; (C) Median raphe cysts; and (D) Angiokeratoma of Fordyce.

Figure 1. Photographic examples of common benign penile dermatological presentations: (A) benign pearly penile papules; (B) Fordyce spots; (C) median raphe cysts; and (D) angiokeratoma of Fordyce.

Reproduced from Hall A. Atlas of male genital dermatology. Springer Nature Switzerland AG, 2019, doi: 10.1007/978-3-319-99750-6, with permission from Springer Nature Switzerland AG.39


Red penile lesions

Genital disease is mostly non-infectious skin disease

Isolated glans inflammation is termed balanitis, whereas balanoposthitis encompasses reactions involving the glans and foreskin. These terms describe red genital dermatoses but do not specify the underlying cause. The mnemonic ‘RED-PENIS’ is helpful for recalling these aetiologies (Table 1).


Table 1. Red penile dermatoses – organised by the mnemonic ‘RED-PENIS’. Click here to enlarge


Reactive arthritis

Reactive arthritis is a multisystem autoimmune inflammatory condition with a genetic predisposition, characterised by urethritis, arthritis and conjunctivitis with cutaneous involvement (Table 1, section 1.1).5 It most commonly affects young men aged 20–30 years, preceded by a triggering infection.6

Eczema/dermatitis

Irritant dermatitis is common and is often misdiagnosed, especially in uncircumcised men (Table 1, section 1.2), as the preputial recess is an intertriginous site where skin rests against. Scrotal skin is particularly susceptible, and identifying a single causative agent is challenging.7 Uncontrolled skin inflammation over time can lead to lichenification, characterised by scaly, thickened skin with surface excoriation. Atopic dermatitis should be considered in association with previous atopy.

Allergic contact dermatitis of the male genital skin manifests as acute, severe dermatitis. A thorough history, patch testing and avoiding allergen exposure form the cornerstone of management.

Drug reaction

An immunological reaction to a range of drugs, causing a fixed reaction of variable cutaneous involvement (Table 1, section 1.3), occur on the genitalia in 20% of patients, and might be immediate or delayed up to one to two months.8

Psoriasis

Psoriasis affects approximately 3% of the population and 29–40% will experience genital manifestations (Table 1, section 1.4).9,10 Over two-thirds of men with chronic plaque psoriasis will experience genital involvement at some point in their disease course, characterised by salmon-red, scaly plaques. Genital psoriasis might occur independently but is frequently associated with inverse (flexural) psoriasis, often impacting the groin.11 Patient concern centres around appearance and negative impacts on sexual wellbeing. When diagnosis is uncertain, biopsy can rule out neoplasia, particularly for solitary glans lesions.12

Neoplasia
Penile intraepithelial neoplasia

Penile intraepithelial neoplasia (PIN) encompasses in situ squamous cell carcinoma (SCC) and erythroplasia of Queyrat. PIN is a non-invasive, pre-malignant proliferation of cells demonstrating variable levels of abnormality including keratinisation and nuclear atypia (Table 1, section 1.6.1).13 This condition can be differentiated based on cell-turnover drivers, including lesions arising from human papillomavirus (HPV) infections and chronic inflammation.14,15 Diagnosis is made by biopsy or excision. Regular surveillance is crucial as the recurrence rate is nearly 50%; however, with adequate treatment only 2% will progress to invasive carcinoma.16

Squamous cell carcinoma of the penis

Penile SCC is a rare but potentially aggressive malignancy that requires urgent management by a uro-oncologist (Table 1, section 1.6.2). The contemporary five-year survival for regionally advanced disease is 51%.17 Australian penile cancer incidence is <0.1 per 100,000 or approximately 300 diagnoses per year.18 Early treatment is paramount to penile-preserving intervention and survival. However, many men experience a treatment delay of more than six months due to social stigma, neglect and access to care, resulting in poorer outcomes.19 Palpable inguinal lymphadenopathy will be present in 28–64% of men at presentation, with almost 50% of these representing regionally advanced disease.19

Diagnosis is by excisional biopsy and minimally invasive sentinel lymph node biopsy.20 For low-risk penile SCC, early surgical intervention might be curative. There is a minimal role for chemoradiotherapy in physically fit patients with lymph node-positive disease.21,22 Radical lymphadenectomy offers the best outcomes for high-risk disease.23 Although more research is needed for this rare disease, recent data suggest that men experience better outcomes when managed by an experienced uro-oncology team at a high-volume tertiary hospital.24

Infections
Non-sexually transmitted

Opportunistic fungal infection is typically caused by the Candida species. Uncircumcised men with pre-existing immunocompromise are most at-risk
(Table 1, section 1.7.1).25 Diagnosis is confirmed through a skin swab. Effective treatment usually only requires a topical imidazole cream. Persistent candidal infection might require oral treatment agents.

Sexually transmitted

Approximately one in six Australians might contract an STI in their lifetime.26 Partner contact tracing should be conducted whenever possible. Genital warts (Condyloma acuminata) are common in the anogenital region, caused by specific types of HPV (Table 1, section 1.7.2). Although primarily attributed to HPV types 6 and 11, co-infection with high-risk types 16 and 18 can lead to malignant transformation.27 Treatments include cryotherapy, topical imiquimod and podophyllotoxin. There is no curative treatment as the virus embeds within host cell DNA.28 All patients should undergo partner contact tracing, and female partners should undergo a swab for HPV DNA detection. Routine vaccination of all adolescents with a HPV vaccination is an important public health measure to reduce the likelihood of infection.

High-risk individuals and those aged <26 years should receive the Gardasil-9 vaccine.29

Genital herpes (herpes simplex virus-2) can be confirmed on dry swab PCR (Table 1, section 1.7.3). Patients often present with first reactivation of the virus and can be effectively treated with topical or oral antivirals.

Primary syphilis (Treponema pallidum) in males typically presents initially with a painless chancre30 (Table 1, section 1.7.4), although these might be overlooked at examination if occurring in the oral mucosa or rectally. Untreated syphilis can ultimately affect many organ systems. High-risk groups include those engaging in unprotected sex with multiple partners and is more prevalent in men who have sex with men. Diagnosis requires a combination of serology and nucleic acid amplification tests from a lesion swab. Patients should be screened for co-infection with HIV.30

Sclerosis
Lichen planus

Lichen planus is a multifocal inflammatory skin condition that occasionally presents on genitalia in both males and females (Table 1, section 1.8.1). Chronic ulcerative lichen planus can lead to genomic instability, increasing malignant potential.31 Careful monitoring and consideration of circumcision is critical for mitigating the risk of penile SCC.

Plasma cell balanitis (Zoon’s)

Zoon’s balanitis (plasma cell balanitis) occurs in uncircumcised older males (Table 1, section 1.8.2). It might develop gradually over months to years and is generally asymptomatic.32 A biopsy is recommended to rule out inflammatory or premalignant conditions.

Genital dysaesthesia

Male genital dysaesthesia usually presents as a burning sensation of the genital skin, akin to vaginal vulvodynia (Table 1, section 1.8.3).33 In more severe cases, male genital dysaesthesia might be painful, resulting in dyspareunia and avoidance of sexual activity. Specialist referral is often warranted.

White lesions
Lichen sclerosus

Lichen sclerosus is a chronic, sclerosing inflammatory condition of uncertain cause of the anogenital skin (Table 2, section 2.1).34 Biopsy should be considered when the diagnosis is uncertain. Untreated cases with persistent phimosis and chronic inflammation can lead to malignant transformation, but there is debate on this issue. The lifetime risk of malignant transformation has not been established.35,36


Table 2. White penile dermatoses. Click here to enlarge


Phimosis

In Australia, circumcision rates have declined, dropping from a peak of 85% in the 1950s to 19% in 2019.37 Physiological phimosis is normal at birth and might variably persist in children. Phimosis is considered physiological if penile function or voiding are unaffected.38

Pathological phimosis exists when the foreskin remains non-retractile beyond puberty, resulting in problematic voiding or dyspareunia (Table 2, section 2.2). Retraction of a pathologically phimotic foreskin might lead to a tight ‘waisting’ of the band around the glans or penile shaft.38

Lichen sclerosus with phimosis can lead to pinhole phimosis, causing painful erections and dyspareunia, and rarely urinary obstruction or recurrent infections, requiring circumcision.34

Investigations

All investigations for genital skin lesions are specific to the suspected pathology and should be considered in the setting of detail history and examination (Table 3). Histopathological analysis is an invaluable diagnostic tool for penile skin dermatoses. It is crucial to rule out premalignant or malignant disease, but histopathology might have limitations in interpretation of inflammatory lesions (Figure 2). The commonest complications of genital skin biopsies are vasovagal reactions, bleeding and scarring. All biopsies should be performed after informed consent is obtained, under local anaesthetic, in a sterile fashion.

Table 3. Investigations and procedures useful for the diagnosis of penile dermatoses in the general practice setting
Investigation Examples Procedure
UVA (Wood lamp)
  • Erythrasma
  • Pigmentation disorders
  • Fungal infection
Utilising UV light from different sources from mercury vapour to LEDs. A range of pathologies fluoresce variably under UV light
Bedside microscopy
  • Scabies
  • Pubic lice
A microscopic examination of skin scraping might reveal
skin mite/insect infestation
Skin swab/laboratory MCS
  • HSV
  • Neisseria gonorrhoeae
  • Chlamydia trachomatis
Useful for bacterial/fungal infections. Might also increase detection of STIs through NAT PCR
Serological testing
  • Syphilis, HBV, HCV, HIV
Screening for underlying STI, if indicated. Completion screening for other STIs is mandatory if one is found
Skin patch testing
  • Allergic contact dermatitis
Patch testing against common allergens
Procedure Indication Technique
Punch biopsy (3–4 mm)
  • Non-pigmented lesions of glans
  • Suspected non-malignant lesions
Rotate the disposable punch biopsy without pressure. Elevate the specimen with a needle and cut the specimen at proximally. An absorbable suture might be used for haemostasis
Deep incisional biopsy
Excisional biopsy
  • Suspicion of invasive cancer
  • Pigmented lesions
Using a small blade, excise the lesion with some normal tissue around it (skin margin), in an elliptical fashion. An absorbable suture(s) might be used for haemostasis
Shave biopsy
  • Pigmented lesions
  • Lesions on the penile shaft
A flexible razor or scalpel might be used to shave the lesion. Chemical haemostasis might be utilised in this type of biopsy
Curette/snip biopsies
  • Pedunculated lesions
A blade might be used to remove a lesion on a stalk
HBV, hepatitis B virus; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HSV, herpes simplex virus; LEDs, light emitting diodes; MCS, microscopy culture and sensitivity; NAT PCR, nucleic acid testing by polymerase chain reaction; STI, sexually transmitted infection; UV, ultraviolet; UVA, ultraviolet A.

Figure 2. Simplified algorithm for approach to genital lesions.

Figure 2. Simplified algorithm for approach to genital lesions.

HSV, herpes simplex virus; PIN, penile intraepithelial neoplasia; SCC, squamous cell carcinoma.


Conclusion

Urological dermatology can be a complex area for general practitioners and urologists, as it encompasses diverse pathology with overlapping clinical presentations. Fortunately, many can be effectively managed in a primary care setting. However, considering a biopsy or seeking multidisciplinary specialist guidance is crucial if there is uncertainty in diagnosis or if initial treatments do not lead to timely improvement. This proactive approach will alleviate patient anxiety and ensure optimal care.

Key points

  • Normal variations and appearance in genital skin are common and might cause unnecessary anxiety for patients and physicians alike.
  • Genital skin disease is mostly non-infectious in aetiology.
  • Pathological phimosis is best treated with upfront topical corticosteroid therapy referred for consideration of circumcision if refractory.
  • Opportunistic screening and prevention of STIs should be undertaken whenever appropriate, especially in the context of co-infection.
  • Genital skin biopsy is essential to confirm or rule out penile neoplasia.
Competing interests: None.
Provenance and peer review: Commissioned, externally peer reviewed.
Funding: None.
Correspondence to:
Henry.yc.pan@gmail.com
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log
References
  1. Nicol A, Chung E. Male sexual dysfunction: Clinical diagnosis and management strategies for common sexual problems. Aust J Gen Pract 2023;52(1-2):41–45. doi: 10.31128/AJGP-09-22-6559. Search PubMed
  2. Mallon E, Hawkins D, Dinneen M, et al. Circumcision and genital dermatoses. Arch Dermatol 2000;136(3):350–54. doi: 10.1001/archderm.136.3.350. Search PubMed
  3. O’Brien J, Teh KCJ, Kelly B, et al. Machining accuracy in uro-urology diagnostics: A pilot study on the role of machine learning to diagnose penile cancer. BJU Int 2023;131 Supp 1:4–82. Search PubMed
  4. Michajłowski I, Sobjanek M, Michajłowski J, Włodarkiewicz A, Matuszewski M. Normal variants in patients consulted in the dermatology clinic for lesions of the male external genitalia. Cent European J Urol 2012;65(1):17–20. doi: 10.5173/ceju.2012.01.art5. Search PubMed
  5. Stavropoulos PGSE, Soura E, Kanelleas A, Katsambas A, Antoniou C. Reactive arthritis. J Eur Acad Dermatol Venereol 2015;29(3):415–24. doi: 10.1111/jdv.12741. Search PubMed
  6. Braun J, Kingsley G, van der Heijde D, Sieper J. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol 2000;27(9):2185–92. Search PubMed
  7. Morris BJ, Krieger JN. Penile inflammatory skin disorders and the preventive role of circumcision. Int J Prev Med 2017;8(1):32. doi: 10.4103/ijpvm.IJPVM_377_16. Search PubMed
  8. Mahboob A, Haroon TS. Drugs causing fixed eruptions: A study of 450 cases. Int J Dermatol 1998;37(11):833–38. doi: 10.1046/j.1365-4362.1998.00451.x. Search PubMed
  9. Meeuwis KA, de Hullu JA, Massuger LF, van de Kerkhof PC, van Rossum MM. Genital psoriasis: A systematic literature review on this hidden skin disease. Acta Derm Venereol 2011;91(1):5–11. doi: 10.2340/00015555-0988. Search PubMed
  10. Armstrong AW, Mehta MD, Schupp CW, Gondo GC, Bell SJ, Griffiths CEM. Psoriasis prevalence in adults in the United States. JAMA Dermatol 2021;157(8):940–46. doi: 10.1001/jamadermatol.2021.2007. Search PubMed
  11. Micali G, Verzì AE, Giuffrida G, Panebianco E, Musumeci ML, Lacarrubba F. Inverse psoriasis: From diagnosis to current treatment options. Clin Cosmet Investig Dermatol 2019;12:953–59. doi: 10.2147/CCID.S189000. Search PubMed
  12. Sun C, Muir J. A solitary penile lesion. Aust J Gen Pract 2021;50(12):911–13. doi: 10.31128/AJGP-08-20-5583. Search PubMed
  13. Tan KB, Tan SH, Aw DC, et al. Simulators of squamous cell carcinoma of the skin: Diagnostic challenges on small biopsies and clinicopathological correlation. J Skin Cancer 2013;2013:752864. doi: 10.1155/2013/752864. Search PubMed
  14. Barnholtz-Sloan JSMJ, Maldonado JL, Pow-sang J, Giuliano AR. Incidence trends in primary malignant penile cancer. Urol Oncol 2007;25(5):361–67. doi: 10.1016/j.urolonc.2006.08.029. Search PubMed
  15. Sanchez DF, Cañete S, Fernández-Nestosa MJ, et al. HPV- and non-HPV-related subtypes of penile squamous cell carcinoma (SCC): Morphological features and differential diagnosis according to the new WHO classification (2015). Semin Diagn Pathol 2015;32(3):198–221. doi: 10.1053/j.semdp.2014.12.018. Search PubMed
  16. Straub Hogan MM, Spieker AJ, Orejudos M, et al. Pathological characterization and clinical outcome of penile intraepithelial neoplasia variants: A North American series. Mod Pathol 2022;35(8):1101–09. doi: 10.1038/s41379-022-01020-y. Search PubMed
  17. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023;73(1):17–48. doi: 10.3322/caac.21763. Search PubMed
  18. Fu L, Tian T, Yao K, et al. Global pattern and trends in penile cancer incidence: Population-based study. JMIR Public Health Surveill 2022;8(7):e34874. doi: 10.2196/34874. Search PubMed
  19. Stecca CE, Alt M, Jiang DM, et al. Recent advances in the management of penile cancer: A contemporary review of the literature. Oncol Ther 2021;9(1):21–39. doi: 10.1007/s40487-020-00135-z. Search PubMed
  20. O’Brien JS, Teh J, Chen K, Kelly BD, Chee J, Lawrentschuk N. Dynamic sentinel lymph node biopsy for penile cancer: Accuracy is in the technique. Urology 2022;164:e308. doi: 10.1016/j.urology.2022.02.014. Search PubMed
  21. Marconnet L, Rigaud J, Bouchot O. Long-term follow up of penile carcinoma with high risk for lymph node invasion treated with inguinal lymphadenectomy. J Urol 2010;183(6):2227–32. doi: 10.1016/j.juro.2010.02.025. Search PubMed
  22. Martin TG, Goddard JC, Terry TR, Summerton DJ. Inguinal lymphadenectomy for squamous cell cancer of the penis—Experience of a UK Supra-Regional Network. Br J Med Surg Urol 2012;5(5):241–47. doi: 10.1016/j.bjmsu.2011.12.009. Search PubMed
  23. O’Brien JS, Perera M, Manning T, et al. Penile cancer: Contemporary lymph node management. J Urol 2017;197(6):1387–95. doi: 10.1016/j.juro.2017.01.059. Search PubMed
  24. Williams SB, Ray-Zack MD, Hudgins HK, et al. Impact of centralizing care for genitourinary malignancies to high-volume providers: A systematic review. Eur Urol Oncol 2019;2(3):265–73. doi: 10.1016/j.euo.2018.10.006. Search PubMed
  25. Lisboa C, Santos A, Dias C, Azevedo F, Pina-Vaz C, Rodrigues A. Candida balanitis: Risk factors. J Eur Acad Dermatol Venereol 2010;24(7):820–26. doi:10.1111/j.1468-3083.2009.03533.x Search PubMed
  26. Grulich AE, de Visser RO, Badcock PB, et al. Knowledge about and experience of sexually transmissible infections in a representative sample of adults: The Second Australian Study of Health and Relationships. Sex Health 2014;11(5):481–94. doi: 10.1071/SH14121. Search PubMed
  27. Djajadiningrat RS, Jordanova ES, Kroon BK, et al. Human papillomavirus prevalence in invasive penile cancer and association with clinical outcome. J Urol 2015;193(2):526–31. doi: 10.1016/j.juro.2014.08.087. Search PubMed
  28. Williams VM, Filippova M, Soto U, Duerksen‑Hughes PJ. HPV-DNA integration and carcinogenesis: Putative roles for inflammation and oxidative stress. Future Virol 2011;6(1):45–57. doi: 10.2217/fvl.10.73. Search PubMed
  29. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook. Australian Government Department of Health and Aged Care, 2022. Available at https://immunisationhandbook.health.gov.au [Accessed 1 November 2023]. Search PubMed
  30. Weerasinghe M, Ooi C. Genital ulcers. Aust J Gen Pract 2022;51(11):840–43. doi: 10.31128/AJGP-06-22-6463. Search PubMed
  31. Khurana A, Tandon S, Marfatia YS, Madnani N. Genital lichen planus: An underrecognized entity. Indian J Sex Transm Dis AIDS 2019;40(2):105–12. doi: 10.4103/ijstd.IJSTD_45_19. Search PubMed
  32. Dayal S, Sahu P. Zoon balanitis: A comprehensive review. Indian J Sex Transm Dis AIDS 2016;37(2):129–38. doi: 10.4103/0253-7184.192128. Search PubMed
  33. Markos AR. The male genital skin burning syndrome (Dysaesthetic Peno/Scroto-dynia). Int J STD AIDS 2002;13(4):271–72. doi: 10.1258/0956462021924938. Search PubMed
  34. Clouston D, Hall A, Lawrentschuk N. Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int 2011;108 Suppl 2:14–19. doi: 10.1111/j.1464-410X.2011.10699.x. Search PubMed
  35. Minhas S, Manseck A, Watya S, Hegarty PK. Penile cancer – Prevention and premalignant conditions. Urology 2010;76 Suppl 1:S24–35. doi: 10.1016/j.urology.2010.04.007. Search PubMed
  36. Barbagli G, Palminteri E, Mirri F, Guazzoni G, Turini D, Lazzeri M. Penile carcinoma in patients with genital lichen sclerosus: A multicenter survey. J Urol 2006;175(4):1359–63. doi: 10.1016/S0022-5347(05)00735-4. Search PubMed
  37. Qin KR, Paynter JA, Wang LC, Mollah T, Qu LG. Early childhood circumcision in Australia: Trends over 20  years and interrupted time series analysis. ANZ J Surg 2021;91(7–8):1491–96. doi: 10.1111/ans.16927. Search PubMed
  38. McGregor TB, Pike JG, Leonard MP. Pathologic and physiologic phimosis: Approach to the phimotic foreskin. Can Fam Physician 2007;53(3):445–48. Search PubMed
  39. Hall A. Atlas of male genital dermatology. Springer Nature, 2019. doi: 10.1007/978-3-319-99750-6. Search PubMed

DermatologyMen's healthUrology

Download article